Knights of Columbus Asset Advisors LLC
Position in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 1688666
NEW HAVEN, CT
Position in RYTM
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,003,314
+$647,539 QoQ
Shares Held
18,043
+15.7% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#134
of 302 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Knights of Columbus Asset Advisors LLC holds $27,324,036 across 16 Biotechnology names. RYTM ranks #4 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
14,071 | $3,444,158 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
23,831 | $2,789,895 | |
| 3 | KYMR |
Kymera Therapeutics, Inc.
|
18,313 | $2,099,951 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
This page
|
18,043 | $2,003,314 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
50,156 | $1,941,037 | |
| 6 | IDYA |
IDEAYA Biosciences, Inc.
|
47,328 | $1,763,914 | |
| 7 | DNLI |
Denali Therapeutics Inc.
|
67,591 | $1,738,440 | |
| 8 | EWTX |
Edgewise Therapeutics, Inc.
|
38,641 | $1,569,983 |
All Filings in RYTM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,003,314 | 18,043 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,355,775 | 15,589 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,104,010 | 10,314 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||